Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial
Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference4%
- Check21 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, melanoma, and rare diseases, which may impact access to important medical information.SummaryDifference0.6%
- Check28 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to genetics, melanoma, rare diseases, and clinical trials, enhancing the resource's breadth of information.SummaryDifference5%
- Check35 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check64 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.